http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
만성 C형 간염의 신이식 환자에서 페그인터페론 알파와 리바비린 병합치료로 치유한 1예
석민규 ( Min Gue Seok ),이태희 ( Tae Hee Lee ),윤성로 ( Sung Ro Yun ),황원민 ( Won Min Hwang ),윤세희 ( Se Hee Yoon ),최인수 ( In Soo Choe ),강성주 ( Seong Joo Kang ),홍주영 ( Ju Young Hong ),김대성 ( Dae Sung Kim ) 영남대학교 의과대학 2016 Yeungnam University Journal of Medicine Vol.33 No.2
Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.